L26/P-747 Transcriptomic regulation of oocyte-secreted factors and gonadotropin receptor expression: Influence of maturation trigger variability in controlled ovarian stimulation cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C.A. Susanto und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does variation in oocyte maturation trigger types elicit a distinct transcriptomic signature in gonadotropin receptors and oocyte-secreted factors? Summary answer Gonadotropin receptor expression at the transcriptomic level appears to be modulated by the type of trigger,while no difference in the OSF expression and IVF outcomes. What is known already The type of oocyte maturation trigger has been associated with distinct gene expression patterns in mural granulosa and cumulus cells, including gonadotropin receptors. Growth differentiation factor 9 (GDF9) and bone morphogenesis protein 15 (BMP15), are well-established regulators of folliculogenesis and are closely linked to oocyte competence. However, the extent to which trigger-associated transcriptomic expression differences translate into biologically and clinically relevant IVF outcomes remains to be clarified further. Study design, size, duration This multi-center prospective observational study took place at Bocah Fertility Center and Yasmin IVF Clinic, in Jakarta, Indonesia, between August and December 2025. The study enrolled 90 infertile women undergoing an IVF program with an antagonist protocol, followed by receiving either a dual trigger (triptoreline 0.2 mg plus hCG 250 mcg), GnRH agonist (triptoreline 0.2 mg), or hCG (250 mcg). All patients provided written informed consent to participate. Participants/materials, setting, methods a total of 51 women were assigned to the dual trigger group, 27 to the GnRH agonist group, and 12 to the hCG group. Mural granulosa and cumulus cells were collected from each retrieved oocyte. Total RNA was isolated using Total RNA Mini Kit (Gegeaid), followed by cDNA synthesis with ReverTra Ace TM qPCR Kit (Toyobo). Real-time quantitative PCR was then performed to determine the absolute gene copy number of the target transcript. Main results and the role of chance LHR expression was highest in the dual trigger group, followed by the GnRH agonist and hCG group, although it did not reach statistical significance (0.85E-3, 0.52E-3, and 0.003E-3,respectively, p = 0.071). In contrast, FSHR expression differed significantly among the three groups (7.23E-9, 4.59E-9, and 0.23E9, respectively, p = 0.048). Post hoc analysis confirms significantly higher FSHR expression in the GnRH agonist compared with the hCG group (p < 0.05). No significant differences were observed among the dual, GnRH agonist, and hCG in the expression of GDF9 (1.98E-9, 1.85E-9, and 0.47E-9, respectively, p > 0.05) and BMP15 (1.16E-9, 1.71E-9, and 0.63E-9,respectively, p > 0.05). Multivariate analysis, adjusting for the type of gonadotropins used, revealed that compared with follitropin alpha/delta, patients receiving HP-hMG/HP-hCG exhibited lower FSHR expression (Coefficient -0.98, 95% CI -1.66 to -0.10,p = 0.005). With respect to IVF outcomes, the GnRH agonist group yielded a significantly higher number of retrieved oocytes, mature oocytes, fertilized oocytes, and the number of cleavages (p < 0.05). However, this apparent advantage did not persist to the blastocyst stage. Eventually, no significant differences in clinical pregnancy were observed among the trigger either before or after adjustment for the type of gonadotropins used (p > 0.05). Limitations, reasons for caution Relatively small sample size in the hCG group may have limited statistical power to detect differences in gene expression. In addition,sampling at a single time point,36-38 hours after trigger administration,may not adequately capture dynamic transcriptomic changes. Further investigation with a balanced, powered randomized design is required to confirm it’s validation. Wider implications of the findings Different trigger strategies seem to modulate the expression of gonadotropin receptors at the transcriptomic level, reflecting trigger-specific molecular responses within follicular cells. These findings highlight the complexity of folliculogenesis regulation and support further investigation into a personalized trigger selection approach. Trial registration number No
Zitieren
APA
Susanto, C., Wiweko, B., Natadisastra, R., Hestiantoro, A., Kemal, A., Maidarti, M., Pratama, G., Sumapraja, K., Leo, B., Dewi, A., Olivia, S., Wahono, W., Chayadi, T., & Marwali, L. (2026). L26/P-747 Transcriptomic regulation of oocyte-secreted factors and gonadotropin receptor expression: Influence of maturation trigger variability in controlled ovarian stimulation cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1074
Vancouver
Susanto C, Wiweko B, Natadisastra R, Hestiantoro A, Kemal A, Maidarti M, et al. L26/P-747 Transcriptomic regulation of oocyte-secreted factors and gonadotropin receptor expression: Influence of maturation trigger variability in controlled ovarian stimulation cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1074
BibTeX
@article{Susanto2026,
author = {Susanto, C.A. and Wiweko, B. and Natadisastra, R.M. and Hestiantoro, A. and Kemal, A. and Maidarti, M. and Pratama, G. and Sumapraja, K. and Leo, B. and Dewi, A.K. and Olivia, S. and Wahono, W. and Chayadi, T. and Marwali, L.S.},
title = {L26/P-747 Transcriptomic regulation of oocyte-secreted factors and gonadotropin receptor expression: Influence of maturation trigger variability in controlled ovarian stimulation cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1074}
}
EUVIMED